Sort
82,697 grants matching “vaccine development”
The Immunobiology of Marrow Allografts for Leukemia
$2,943,616Sloan-Kettering Institute For Cancer Res · P01 · FY2005 · CA
Philadelphia HIV Therapeutics and Prevention Clinical Trials Unit
$2,942,898Pablo Tebas · University Of Pennsylvania · UM1 · FY2019 · AI
Strategies for Eliciting bnAbs against Conserved HIV-1 Quaternary Epitopes
$2,942,662Abraham Pinter · Univ Of Med/Dent Of Nj-Nj Medical School · P01 · FY2011 · AI
The UNC/Emory Center for Innovative Technology (iTech) across the prevention and care continuum
$2,942,520Lisa B Hightow-Weidman · Univ Of North Carolina Chapel Hill · U19 · FY2017 · HD
Cervical cancer and human papillomavirus (HPV) infection
$2,941,829Mark Schiffman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
Vanderbilt HIV Clinical Trials Unit
$2,941,559David W Haas · Vanderbilt University Medical Center · UM1 · FY2019 · AI
Small molecule stimulators for use as adjuvants for antiviral vaccines
$2,941,503Michael J Gale · University Of Washington · N01 · FY2012 · AI
SPORE IN BREAST CANCER
$2,941,349Johns Hopkins University · P50 · FY2002 · CA
Penn Center for AIDS Research
$2,940,869Ronald G Collman · University Of Pennsylvania · P30 · FY2024 · AI
Lead Optimization and Preclinical Development of Human Nicotine-Specific mAbs
$2,939,717Matthew W Kalnik · Antidote Therapeutics, Inc. · R01 · FY2016 · DA
Systems Biological Analysis of Innate and Adaptive Responses to Vaccination
$2,937,945Bali Pulendran · Emory University · U19 · FY2013 · AI
Protein homeostasis mechanisms underlying enterovirus replication and evolution
$2,937,748Raul Andino · University Of California, San Francisco · P01 · FY2011 · AI
ACE2 immunodecoys for long-lasting immunoprophylaxis against sarbecovirus and merbecoviruses that target human ACE2
$2,937,578Samuel Lai · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AI
UofL RBL Operations, Workforce Development and Pandemic Preparedness Research
$2,935,664Kenneth E Palmer · University Of Louisville · UC7 · FY2023 · AI
Targeting the Chemokine System to Sensitize Tumors to Immunotherapy
$2,934,547Pawel Kalinski · Roswell Park Cancer Institute Corp · P01 · FY2021 · CA
Bone Marrow Transplantation in Human Disease
$2,933,594Richard J Jones · Johns Hopkins University · P01 · FY2010 · CA
Role of antigen-specific T cell responses in the control of TB
$2,933,100Henry M Blumberg · Emory University · U19 · FY2015 · AI
Stony Brook University Laboratory for Comparative Medicine to Support Pandemic Preparedness
$2,933,079David G Thanassi · State University New York Stony Brook · G20 · FY2022 · AI
Project 6 - Development of Antivirals against Alphaviruses
$2,932,338Margaret Kielian · Emory University · U19 · FY2022 · AI
Penn Center for AIDS Research
$2,931,287Ronald G Collman · University Of Pennsylvania · P30 · FY2025 · AI
Columbia Collaborative HIV/AIDS Clinical Trials Unit
$2,931,000Scott M Hammer · Columbia University Health Sciences · U01 · FY2009 · AI
Influenza Immunity: Protective Mechanisms Against Pandemic Respiratory Virus
$2,928,907Mark M Davis · Stanford University · U19 · FY2010 · AI
Immunobiology for Marrow Allografts for Leukemia
$2,928,248Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA
Immunobiology for Marrow Allografts for Leukemia
$2,928,248Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2016 · CA
Immunobiology for Marrow Allografts for Leukemia
$2,928,248Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2017 · CA